Page last updated: 2024-12-09

n-methylthiourea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylthiourea : A member of the class of thioureas that is thiourea in which one of the hydrogens is replaced by a methyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2723704
CHEMBL ID4475870
CHEBI ID188347
MeSH IDM0042786

Synonyms (48)

Synonym
c2h6n2s
methyl-thiourea
methylthiocarbamide
nsc30213
1-methylthiocarbamide
598-52-7
nsc-30213
urea, 1-methyl-2-thio-
wln: suyzm1
n-methylthiourea
1-methyl-2-thiourea
thiourea, methyl-
n-methylthiocarbamide
methylthiourea
1-methylthiourea
inchi=1/c2h6n2s/c1-4-2(3)5/h1h3,(h3,3,4,5
n-methylthiourea, 97%
ai3-52471
monomethylthiourea
methyl thiourea
einecs 209-936-6
methyl-2-thiourea
pseudourea, 1-methyl-2-thio-
nsc 30213
thourea, methyl-
methylisothiourea
M0619
CHEBI:188347
AKOS000121507
A832505
STL122193
n-methyl thiourea
unii-hrk3dmo87x
hrk3dmo87x ,
thiourea, n-methyl-
FT-0647492
n-methyl-thiourea
methylthiopseudourea
DS-2268
DTXSID90208533
F0001-1569
mfcd00004938
quadrapure(r) tu, macroporous, 400-600 mum particle size
CHEMBL4475870
n-methyl-2-thiourea
EN300-21100
2-chloro-6-methoxyquinoline-3-carbaldehydeoxime
CS-W011347

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Similarly, ring fusion of a benzene nucleus to the C-4,5 double bond, forming 2-mercapto-1-methylbenzimidazole, abolished the toxic potency."( Evidence for the involvement of N-methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione-depleted mice: structure-toxicity and metabolic studies.
Kawazoe, S; Mizutani, T; Murakami, M; Shirai, M; Yoshida, K, 2000
)
0.59
" Administration of this drug, often in a chronic manner, is associated with several adverse drug reactions in humans, including life-threatening hepatotoxicity."( Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes.
Babaei, H; Eghbal, M; Heidari, R, 2013
)
0.39

Pharmacokinetics

ExcerptReferenceRelevance
" A number of pharmacokinetic parameters were calculated from serum concentration data in rabbits and humans."( Liquid chromatographic determination of noxytiolin and 1-methyl-2-thiourea in serum: application to pharmacokinetic studies in rabbits and humans.
Bigot, MC; Bricard, H; Debruyne, D; Moulin, MA, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
drug metabolitenull
hepatotoxic agentA role played by a chemical compound exihibiting itself through the ability to induce damage to the liver in animals.
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
thioureasCompounds of general formula RR'NC(=S)NR''R'''.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Taste receptor type 2 member 38Homo sapiens (human)EC50 (µMol)600.00000.00491.36102.3000AID1619468
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Taste receptor type 2 member 38Homo sapiens (human)Activity100.00000.15003.256310.0000AID1619467
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
detection of chemical stimulus involved in sensory perception of bitter tasteTaste receptor type 2 member 38Homo sapiens (human)
G protein-coupled receptor signaling pathwayTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityTaste receptor type 2 member 38Homo sapiens (human)
bitter taste receptor activityTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTaste receptor type 2 member 38Homo sapiens (human)
membraneTaste receptor type 2 member 38Homo sapiens (human)
membraneTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (57.14)18.7374
1990's0 (0.00)18.2507
2000's3 (21.43)29.6817
2010's2 (14.29)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.33 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index31.59 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]